arrow
N

Nastya Kassir

roche holding
H指数:14
被引数:536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC Populations

陈, J.; Wada, R.; 张, N.; Graupner, V.; Morris, S.; Hu, Y.; 张, W.; Kassir, N.; Wu, B.; Chan, P. 基于模型的总体生存率在易感顺铂不适用非小细胞肺癌人群中的荟萃分析. CPT 药代动力学与系统药理学. 2026, 15, e70197. [Google Scholar] [CrossRef]

2026-02-161
OAAI
Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: Updated data from the iMATRIX Alectinib phase I/II open-label, multi-center study
2024-09-050
PRE
Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: Data from the iMATRIX Alectinib Phase I/II open-label, multi-center study

Alectinib在患有ALK融合的实体或CNS肿瘤的儿童和青少年中的应用: 来自iMATRIX Alectinib I/II期开放标签,多中心研究的数据

2024-04-050
PRE